Literature DB >> 19029219

MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.

A Seeger1, B Klumpp, U Kramer, N I Stauder, M Fenchel, C D Claussen, S Miller.   

Abstract

Cardiac MRI is known to be diagnostically valuable in cardiac amyloidosis. Several features are frequently found, including myocardial hypertrophy, diastolic dysfunction, a faster gadolinium blood wash out, pleural and pericardial effusions, and diffuse myocardial delayed enhancement. Cardiac MR facilitates the detection of cardiac amyloidosis and allows longitudinal assessment of myocardial function. This pictorial review focuses on cases with histologically proven systemic amyloidosis and cardiac involvement in order to illustrate typical findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029219     DOI: 10.1259/bjr/76104551

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

Review 2.  Differentiation of myocardial scar from potential pitfalls and artefacts in delayed enhancement MRI.

Authors:  E B Turkbey; M S Nacif; R A Noureldin; C T Sibley; S Liu; J A C Lima; D A Bluemke
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

Review 3.  Multimodality imaging in amyloidosis.

Authors:  Stephanie Howard; Jyothi Jagannathan; Katherine Krajewski; Angela Giardino; Katherine Zukotynski; Kevin O'Regan; Irene Ghobrial; Nikhil Ramaiya
Journal:  Cancer Imaging       Date:  2012-04-27       Impact factor: 3.909

4.  Primary systemic amyloidosis: imaging interpretation of this complex multisystemic disease.

Authors:  Indu Mitra; Ken Tung
Journal:  BJR Case Rep       Date:  2016-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.